Findings reveal greater symptomatic burden in female patients with severe asthma under biologic treatment, suggesting the need for tailored care.
Symptomatic burdens are greater in female patients with asthma maintaining exacerbation-free and OCS-free conditions under biologic treatments compared to male counterparts. This sex difference may cause a lower rate of CR in females particularly when CR requires almost complete symptomatic resolution.
No takes yet. Share an insight, caveat, or question.
Hayashi et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: